PRODUCT

2015.11.16 PRODUCTA Joint Development with the National Cancer Cente: Information Regarding the Sale of “ReproHP Medium,” a Culture Fluid for Human Primary Liver Cells with High Levels of Functionality

A Joint Development with the National Cancer Cente: Information Regarding the Sale of “ReproHP Medium,” a Culture Fluid for Human Primary Liver Cells with High Levels of Functionality

2013.11.11 PRODUCTReproCELL Inc. announces the launch of “ReproUNUS”, tailor-made human iPS cell derived disease model cells.

Yokohama, Kanagawa, Japan – ReproCELL Inc. (ReproCELL, CEO: Chikafumi Yokoyama, Ph.D. JASDAQ: 4978) announced today the upcoming launch of“ReproUNUS”in November, 2013. ReproUNUS is a tailor-made human iPS cell derived disease model developed in collaboration with Takara Bio Inc. (Takara, Shiga, Japan, President: Koichi Nakao, TSE Mothers: 4974). With the launch of RepoUNUS, ReproCELL will be able to customize human iPS cells to a customer’s specific request. The product is a combination of human iPS cell development expertise provided by ReproCELL, and novel gene editing techniques from Takara. Genes of interest vary by customer such as pharmaceutical companies and academic research institutes. ReproCELL can cover those different interests by offering tailor-made […]

2013.11.05 PRODUCTReproCELL Inc. announces the launch of “ReproHSC”, culture medium for human hematopoietic stem cells

Yokohama, Kanagawa, Japan – ReproCELL Inc. (ReproCELL, CEO: Chikafumi Yokoyama, Ph.D. JASDAQ: 4978) announced today that the company will launch “ReproHSC”, culture medium for human hematopoietic stem cells co-developed with Nissan Chemical Industries, LTD (Tokyo, Japan, President: Kojiro Kinoshita) in December, 2013. The company will begin offering samples of “ReproHSC” in November, 2013. Hematopoietic stem cells, found in bone marrow and cord blood, can be differentiated into many cell types such as erythrocytes, leukocytes, and blood platelets. While hematopoietic stem cell transplant (bone marrow transplant / cord blood transplant) has been utilized as an effective method of therapy for diseases such as leukemia, chronic myelodysplastic syndrome, and aplastic anemia, there […]

2013.10.30 PRODUCTReproCELL Inc. announces the launch of a newline of human iPSC derived Alzheimer’s disease model neural cells

Yokohama, Kanagawa, Japan – ReproCELL Inc. (ReproCELL, CEO: Chikafumi Yokoyama, Ph.D. JASDAQ: 4978) announced today that the company will launch a new line of human iPS cell derived Alzheimer’s disease model neural cells, “ReproNeuro Glu-AD” based on gene modification technology and iPS cell technology in November, 2013. ReproCELL launched the world’s first human iPS cell derived Alzheimer’s disease model neural cells, “ReproNeuro Ach-AD” in July 2012. The cells have been used by pharmaceutical companies and academic research institutes for Alzheimer’s disease research. Newly launched “ReproNeuro Glu-AD”(glutamatergic neuron) is different from “ReproNeuro Ach-AD”(cholinergic neuron) in terms of neural cell type and function. It is known that the decrease in acetylcholine content […]

2012.07.11 PRODUCTThin layer cardiomyocyte protocols released

New application protocols for thin layered ReproCardio2 (cardiomyocytes derived from human iPS cells) are now available. Please visit the web page below for the details and requesting the protocol. – MEA recordings from beating thin layer formed by ReproCardio 2 – Live imaging of calcium concentration change using ReproCardio 2 thin layer

2012.07.11 PRODUCTNew product information (Alzheimer’s disease model, Ach neurons)

We have uploaded information about our new products of ReproNeuro, human iPSC-derived neurons. Please visit the webpage below for the details. ReproNeuro Ach Kit and Alzheimer’s Disease Model Cells Disease model neurons for Alzheimer’s disease research, and cholinergic neurons derived from human iPS cells.

2012.06.09 PRODUCTReproCELL launches Alzheimer’s disease model based on iPS-derived human neuronal cells

Yokohama, Kanagawa, Japan €- ReproCELL, Inc. (CEO: Chikafumi Yokoyama PhD) announces today that the company will start commercializing human iPS-derived neurons in which an Alzheimer’s disease related gene has been incorporated. ReproCELL’s scientists have successfully incorporated a gene related to Alzheimer’s disease using homologous recombinant genetic engineering technology into undifferentiated human iPS cells and then differentiated them into neurons. In these cells, it has been confirmed that amyloid beta 42 is accumulated at higher levels compared to normal neurons. This phenomena is similar to what is observed in neurons of Alzheimer’s patients. Accordingly, ReproCELL’s scientists believe the newly developed iPS cells can be useful for drug screening to identify new […]

2012.02.01 PRODUCTInstruction movies for human iPSC culture procedure

Instruction movies for human iPS cell culture procedure are now available on our website.

2012.01.13 PRODUCTReproFF2 Customer Feedback

Feedback comments and results from the customers using ReproFF2 are now available on our website. ReproFF2 customer feedback

2011.12.05 PRODUCTReproHepato web page launched

Information about ReproHepato 3A4, a human iPSC-derived hepatocyte product, is now available on ReproCELL website. Updated information will be added continuously so please check the web page often. The product will be launched in Spring 2012. ReproHepato 3A4 web page Inquiry about ReproHepato 3A4